Gossamer Bio

Gossamer Bio is a clinical-stage biopharmaceutical company focused on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH). They are driven by a mission to enhance the lives of patients living with PAH. Gossamer Bio's approach is rooted in the "Gossamer Thread" concept, which emphasizes the importance of strong relationships with patients, employees, shareholders, providers, and partners. Their commitment to these relationships guides their operations and fosters a collaborative and respectful work environment.

Gossamer Bio has assembled a team of experienced industry veterans, scientists, clinicians, and key opinion leaders from leading biotechnology and pharmaceutical companies, as well as academic centers. This diverse and skilled group provides the foundation for the company's rigorous research and development efforts. Gossamer Bio is dedicated to maintaining a scientifically rigorous and inclusive corporate culture where employees strive to deliver innovative and effective therapeutic options to patients.

Gossamer Bio offers flexible work arrangements as part of its commitment to employee well-being. This includes allowing employees to tailor their work schedules to fit their individual needs and preferences. The company values work-life balance and encourages employees to take advantage of their flexible work options.

Gossamer Bio offers a comprehensive benefits package designed to support employees and their families. This includes robust health insurance options covering medical, dental, vision, and flexible spending accounts. It also offers disability and life insurance plans, well-being programs, generous paid time off, and employee discounts. In addition to these, they provide financial benefits like competitive salaries, performance bonuses, employee stock purchase plans, and retirement plans with employer matching. They further emphasize their commitment to employee development through programs like educational assistance, professional development opportunities, and patient advocacy events.

Gossamer Bio is a clinical-stage biopharmaceutical company committed to improving the lives of people living with pulmonary arterial hypertension (PAH). They focus on the development and commercialization of seralutinib, an inhaled inhibitor, as a potential treatment for PAH. Gossamer Bio is driven by a strong sense of community and prioritizes relationships with patients, employees, shareholders, providers, and partners, striving to create a positive and inclusive work environment.

Gossamer Bio fosters a culture that values respect, humility, transparency, dedication, collaboration, and fun. They aim to create a work environment where employees feel empowered to contribute to their mission of improving the lives of patients while fostering a sense of camaraderie and shared purpose.

Gossamer Bio values diversity, equity, and inclusion, recognizing the importance of these principles in fostering a positive and productive work environment. The company aims to build a team that reflects the diverse patient populations it serves and strives to create an inclusive culture where all employees feel valued, respected, and empowered to contribute their unique perspectives and talents. Gossamer Bio is committed to equal opportunity employment and aims to attract, develop, and retain a workforce that is representative of the communities in which it operates.